Cardiomedex vs ChemDiv

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cardiomedex/chemdiv

Category	Cardiomedex	ChemDiv
Listed site	cro	cro
Summary	Cardiomedex is a preclinical CRO specialized in cardiovascular disease models, offering in vivo efficacy studies, ex vivo functional exploration, and in vitro assays for drug candidates targeting heart failure, myocardial infarction, hypertension, and cardiometabolic complications.	ChemDiv is a fully integrated target-to-clinic CRO headquartered in San Diego, CA, offering drug discovery services including medicinal chemistry, CADD, ADME/DMPK, toxicology, and custom synthesis alongside the industry's largest commercial screening library of 1.6M compounds.
Services	Cardiovascular & Metabolic Specialty Services In Vivo Efficacy Models Preclinical In Vivo Studies In Vitro Pharmacology Preclinical In Vitro Studies Translational Research	Discovery Research Target Identification & Validation High-Throughput Screening Medicinal Chemistry Computational & In-Silico Drug Discovery In Vitro Pharmacology In Vitro ADME / DMPK In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vitro Studies Preclinical In Vivo Studies Safety Pharmacology GLP Toxicology Specialized & Large-Animal Models Translational Research
Modalities	Small Molecule	Small Molecule Antibody-Drug Conjugate (ADC) Oligonucleotide Gene Therapy
Indications	Cardiovascular Metabolic	Oncology Immunology Neurology Metabolic Cardiovascular Infectious Disease
Locations	Headquarters, Toulouse, France	Headquarters, San Diego, CA, USA Representative - South Korea, Seongnam-si, Gyeongi-do, South Korea Representative - Japan, Tokyo, Tokyo, Japan Representative - China, Shanghai, Shanghai, China
Certifications	Data not yet provided.	GLP · Identifier: GLP compliant CMP · Identifier: CMP compliant
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.